Investing.com - Eli Lilly (NYSE:LLY) reported fourth quarter earnings that missed analysts' expectations on Wednesday and revenue that topped forecasts.
The firm reported earnings per share of $1.33 on revenue of $6.43B. Analysts polled by Investing.com expected EPS of $1.34 on revenue of $6.28B. That compared to EPS of $1.14 on revenue of $6.16B in the same period a year earlier. The company had reported EPS of $1.39 on revenue of $6.06B in the previous quarter.
For the year, Eli Lilly shares are up 4.07%, under-performing the S&P 500 which is up 10.53% year to date.
Eli Lilly follows other major Healthcare sector earnings this month
On Tuesday, January 22, 2019, J&J reported fourth quarter EPS of $1.97 on revenue of $20.39B, compared to forecasts of EPS of $1.95 on revenue of $20.2B.
Pfizer earnings beat analyst's expectations on Tuesday, January 29, 2019, with fourth quarter EPS of $0.64 on revenue of $13.98B. Investing.com analysts expected EPS of $0.63 on revenue of $13.9B
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar